Two Sigma Investments’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-39,405
| Closed | -$8.29K | – | 3358 |
|
|
2023
Q2 | $8.29K | Sell |
39,405
-6,050
| -13% | -$1.05K | ﹤0.01% | 2950 |
|
|
2023
Q1 | $7.27K | Buy |
45,455
+717
| +2% | +$318 | ﹤0.01% | 2903 |
|
|
2022
Q4 | $24.8K | Buy |
44,738
+20,449
| +84% | +$17.4K | ﹤0.01% | 2657 |
|
|
2022
Q3 | $29K | Sell |
24,289
-118,809
| -83% | -$128K | ﹤0.01% | 2362 |
|
|
2022
Q2 | $90K | Sell |
143,098
-258,179
| -64% | -$198K | ﹤0.01% | 2278 |
|
|
2022
Q1 | $457K | Sell |
401,277
-127,093
| -24% | -$152K | ﹤0.01% | 2067 |
|
|
2021
Q4 | $1.19M | Sell |
528,370
-969,422
| -65% | -$2.43M | ﹤0.01% | 2397 |
|
|
2021
Q3 | $5.12M | Buy |
1,497,792
+223,526
| +18% | +$689K | 0.01% | 1203 |
|
|
2021
Q2 | $3.81M | Buy |
1,274,266
+236,635
| +23% | +$749K | 0.01% | 1370 |
|
|
2021
Q1 | $3.35M | Buy |
1,037,631
+591,482
| +133% | +$1.97M | 0.01% | 1318 |
|
|
2020
Q4 | $946K | Buy |
+446,149
| New | +$736K | ﹤0.01% | 2057 |
|
|
2020
Q3 | – | Sell |
-13,651
| Closed | -$12K | – | 3681 |
|
|
2020
Q2 | $12K | Sell |
13,651
-4,600
| -25% | -$4.38K | ﹤0.01% | 2876 |
|
|
2020
Q1 | $15K | Sell |
18,251
-9,400
| -34% | -$10.9K | ﹤0.01% | 2981 |
|
|
2019
Q4 | $27K | Sell |
27,651
-6,700
| -20% | -$7.35K | ﹤0.01% | 3587 |
|
|
2019
Q3 | $35K | Sell |
34,351
-4,097
| -11% | -$5.58K | ﹤0.01% | 3371 |
|
|
2019
Q2 | $69K | Sell |
38,448
-4,126
| -10% | -$6.64K | ﹤0.01% | 3229 |
|
|
2019
Q1 | $80K | Sell |
42,574
-48,722
| -53% | -$71.3K | ﹤0.01% | 2918 |
|
|
2018
Q4 | $108K | Buy |
91,296
+20,721
| +29% | +$37.3K | ﹤0.01% | 2801 |
|
|
2018
Q3 | $191K | Buy |
+70,575
| New | +$146K | ﹤0.01% | 3023 |
|
|
2017
Q3 | – | Sell |
-15,897
| Closed | -$25K | – | 3310 |
|
|
2017
Q2 | $25K | Buy |
+15,897
| New | +$30.7K | ﹤0.01% | 2899 |
|
|
2016
Q3 | – | Sell |
-107,301
| Closed | -$143K | – | 3450 |
|
|
2016
Q2 | $143K | Buy |
+107,301
| New | +$502K | ﹤0.01% | 2793 |
|
|
2015
Q1 | – | Sell |
-111,812
| Closed | -$1.89M | – | 2926 |
|
|
2014
Q4 | $1.89M | Buy |
+111,812
| New | +$1.63M | 0.01% | 1047 |
|
Other funds holding INFI
Two Sigma Investments's INFI Position: Q3 2023 in Review
Two Sigma Investments sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 39,405 shares — an estimated $8.29K sold.
Two Sigma Investments first reported a position in INFI in Q4 2014 and held it in 22 quarters. The position peaked at $5.12M in Q3 2021. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Two Sigma Investments reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Two Sigma Investments sold 39,405 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $8.29K.
- Two Sigma Investments first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 22 quarters.
- Two Sigma Investments's Infinity Pharmaceuticals, Inc. position peaked at $5.12M in Q3 2021.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.